Mapping large numbers of results may take a few moments.
Search Results
Showing 101 - 108 of 108 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Torque Bio Inc. | Activity: Research and Development | Company Description Torque Bio is a start-up leveraging the power of technology to develop novel gene therapies. | Location Durham |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |
| |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham |
| |
Company uMETHOD Health Inc. | Activity: Support and Related | Company Description uMethod Health analyzes medical data to identify underlying causes of disease and develop evidence-based personalized care plans to improve outcomes for patients living with chronic diseases. | Location Raleigh |
| |
Company Validic | Activity: Support and Related | Company Description Validic offers health IOT and remote care enablement platform solutions for payers, health systems, health IT, and pharma. | Location Chapel Hill |
| |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham |
| |
Company ZealCare Inc. | Activity: Support and Related | Company Description ZealCare is a tech-enabled disease management company that partners with accountable care organizations and health systems to offer personalized health care for people with complex chronic diseases. | Location Cary |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |